Share on StockTwits

Shares of Johnson & Johnson (NYSE:JNJ) were the recipient of unusually large options trading on Thursday. Stock investors bought 24,910 call options on the stock, American Banking News reports. This represents an increase of 408% compared to the typical volume of 4,903 call options.

A number of research firms have recently commented on JNJ. Analysts at Jefferies Group reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Monday, August 11th. They now have a $108.00 price target on the stock, down previously from $114.00. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $122.00 price target on the stock, up previously from $117.00. Finally, analysts at Deutsche Bank reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $107.00 price target on the stock, up previously from $102.00. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. Johnson & Johnson presently has a consensus rating of “Hold” and an average target price of $98.00.

Johnson & Johnson (NYSE:JNJ) traded up 0.95% on Thursday, hitting $104.19. The stock had a trading volume of 8,357,533 shares. Johnson & Johnson has a 1-year low of $85.50 and a 1-year high of $106.74. The stock has a 50-day moving average of $102.4 and a 200-day moving average of $99.07. The company has a market cap of $293.8 billion and a P/E ratio of 19.08.

Johnson & Johnson (NYSE:JNJ) last released its earnings data on Tuesday, July 15th. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.12. The company had revenue of $19.50 billion for the quarter, compared to the consensus estimate of $18.86 billion. During the same quarter in the previous year, the company posted $1.48 earnings per share. Johnson & Johnson’s revenue was up 9.1% compared to the same quarter last year. Analysts expect that Johnson & Johnson will post $5.92 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 9th. Investors of record on Tuesday, August 26th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date of this dividend is Friday, August 22nd.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.